Streetbeat News

Partnerships

RDNT

WMT

RadNet has announced the launch of MammogramNow, a new screening mammography service, which will debut at the Walmart Supercenter in Milford, Delaware, on December 8th. This service aims to provide convenient and accessible breast cancer screening for women.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 11:02 am

FENC

Fennec Pharmaceuticals Inc. has announced a third closing of $5 million in senior secured promissory notes under an existing agreement with Petrichor. The original deal allowed for up to $20 million in additional financing until December 31, 2023. The agreement has been amended to provide access to up to $15 million more through December 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 10:58 am

NDAQ

Nasdaq (NDAQ) and nuam exchange, formed by the merger of Santiago, Lima, and Colombia stock exchanges, have announced a strategic technology partnership to develop a new marketplace in Latin America. This partnership aims to integrate, develop, and expand the trading platform in the region.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 9:01 am

CLVT

Clarivate has expanded its alliance with VeriSIM Life to accelerate and de-risk research and drug development. This collaboration aims to enhance the drug development process by integrating VeriSIM's BIOiSIM platform with Clarivate's drug, device, and medical literature intelligence. The partnership is expected to improve decision-making and efficiency in the drug development lifecycle.

Portfolio Pulse from Benzinga Newsdesk

December 05, 2023 | 7:05 am

IBM

INTC

META

ORCL

Meta Platforms (META) and International Business Machines (IBM) have formed an AI Alliance with over 50 companies and research institutions, including Intel (INTC) and Oracle (ORCL), to advocate for open AI. The coalition aims to foster open innovation and science in AI, with members supporting open-source technology. Despite past setbacks in AI, both IBM and Meta are contributing to the alliance, with IBM introducing its new Watsonx system and Meta promoting its Llama 2 AI model. The alliance addresses the need for a diversified AI product market, reducing single-vendor dependency risks.

Portfolio Pulse from Navdeep Yadav

December 05, 2023 | 6:48 am

MSFT

Microsoft Corp. has expanded the availability of Copilot, an AI-powered assistant, to all Windows 11 and Windows 10 users. Copilot, which replaces Cortana, is built on Microsoft's partnership with OpenAI, incorporating ChatGPT and Dall-E technologies. It can perform tasks on the computer, summarize open tabs, edit photos, and generate images, offering more functionality than Bing Chat.

Portfolio Pulse from Rounak Jain

December 05, 2023 | 5:33 am

WBD

Former Congressman George Santos, ousted from the House of Representatives amid allegations and federal charges, has joined Cameo, offering video messages for $200 each. Warner Bros. Discovery's HBO Films unit has optioned the rights to a book about Santos for a movie. The book, 'The Fabulist,' details Santos' controversial career and was released on Nov. 28, 2023. Frank Rich is set to work on the movie, which will take a 'darkly comic look' at Santos' story.

Portfolio Pulse from Chris Katje

December 04, 2023 | 11:38 pm

FFNTF

ITHUF

JSDA

XBRAF

XXII

The cannabis industry sees a wave of executive appointments and board updates. Aaron Lopez is now the head of the National Hispanic Cannabis Council. The Blinc Group, 22nd Century Group, and Healing Commercial Real Estate Inc. have appointed new CEOs. 22nd Century Group (XXII) also sold its hemp/cannabis operations to Specialty Acquisition Corporation. Xebra Brands Ltd. (XBRAF) and iAnthus Capital Holdings, Inc. (ITHUF) elected new board directors. 4Front Ventures Corp. (FFNTF), Wana Brands, Jones Soda Co. (JSDA), FundCanna, FloraWorks Holdings Inc., and Ziel announced other key appointments.

Portfolio Pulse from Jelena Martinovic

December 04, 2023 | 10:46 pm

NPCE

NeuroPace has entered into a strategic collaboration to provide biomarker monitoring and data analysis capabilities using its RNS System. A clinical-stage biotechnology company will pay NeuroPace up to $3.7 million over two years for non-exclusive access to these services for its clinical trial patients.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:09 pm

NPCE

NeuroPace, Inc. has entered into a collaboration with Rapport Therapeutics to share site data for Rapport's Phase 2a trial of their GABA A receptor-associated protein compound.

Portfolio Pulse from Charles Gross

December 04, 2023 | 10:09 pm